BSB
VRTX icon

Bangor Savings Bank’s Vertex Pharmaceuticals VRTX Stock Holding History

Bangor Savings Bank’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.22M Buy
4,470
+20
+0.4% +$8.86K 0.16% 51
2026
Q1 		$1.99M Sell
4,450
-126
-3% -$58.8K 0.16% 52
2025
Q4 		$2.07M Sell
4,576
-323
-7% -$139K 0.17% 53
2025
Q3 		$1.92M Sell
4,899
-30
-0.6% -$12.5K 0.16% 60
2025
Q2 		$2.19M Sell
4,929
-406
-8% -$187K 0.2% 51
2025
Q1 		$2.59M Sell
5,335
-218
-4% -$102K 0.24% 42
2024
Q4 		$2.24M Sell
5,553
-171
-3% -$79.3K 0.21% 53
2024
Q3 		$2.66M Sell
5,724
-444
-7% -$213K 0.25% 47
2024
Q2 		$2.89M Sell
6,168
-146
-2% -$63.4K 0.29% 37
2024
Q1 		$2.64M Sell
6,314
-407
-6% -$172K 0.27% 44
2023
Q4 		$2.73M Sell
6,721
-99
-1% -$36.6K 0.3% 40
2023
Q3 		$2.37M Sell
6,820
-171
-2% -$59.8K 0.28% 45
2023
Q2 		$2.46M Buy
6,991
+49
+0.7% +$16.5K 0.28% 44
2023
Q1 		$2.19M Sell
6,942
-39
-0.6% -$11.7K 0.26% 49
2022
Q4 		$2.02M Sell
6,981
-1,057
-13% -$322K 0.24% 55
2022
Q3 		$2.33M Sell
8,038
-78
-1% -$22.4K 0.27% 49
2022
Q2 		$2.29M Sell
8,116
-202
-2% -$54.1K 0.25% 54
2022
Q1 		$2.17M Sell
8,318
-127
-2% -$30.1K 0.23% 59
2021
Q4 		$1.85M Buy
8,445
+446
+6% +$86.7K 0.18% 80
2021
Q3 		$1.45M Buy
7,999
+959
+14% +$187K 0.15% 88
2021
Q2 		$1.42M Buy
+7,040
New +$1.47M 0.16% 85

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Bangor Savings Bank's VRTX Position: Q2 2026 in Review

Bangor Savings Bank increased its Vertex Pharmaceuticals (VRTX) stake by 0.45% in Q2 2026, buying an estimated $8.86K and bringing the position to 4,470 shares worth $2.22M. The position accounts for 0.16% of the portfolio, ranked #51.

Bangor Savings Bank first reported a position in VRTX in Q2 2021 and has held it in 21 quarters since. The position peaked at $2.89M in Q2 2024. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Bangor Savings Bank held 4,470 shares of Vertex Pharmaceuticals worth $2.22M as of Q2 2026.
  • Bangor Savings Bank bought 20 Vertex Pharmaceuticals shares in Q2 2026, an estimated $8.86K.
  • Vertex Pharmaceuticals made up 0.16% of Bangor Savings Bank's portfolio in Q2 2026, its #51 holding.
  • Bangor Savings Bank first reported a position in Vertex Pharmaceuticals in Q2 2021 and has held it in 21 quarters since.
  • Bangor Savings Bank's Vertex Pharmaceuticals position peaked at $2.89M in Q2 2024.
  • 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Bangor Savings Bank's 13F filing for Q2 2026, filed 6 Jul 2026.